Independent prescribing sets the direction of travel for community pharmacy in Northern Ireland
Independent prescribing is the future of community pharmacy, but in Northern Ireland, how we get there matters.
That was the clear message from a panel session at the Northern Ireland Pharmacy Trade Show, where senior leaders from across the pharmacy system came together to explore what independent prescribing means in practice for community pharmacy.
For community pharmacy in Northern Ireland, the conversation has shifted. The question is no longer whether independent prescribing becomes part of everyday practice, but how it is embedded safely, sustainably, and in a way that supports pharmacists and their teams rather than stretching them to breaking point.
Chaired by Lynette Clarke, the session brought together voices from the Pharmaceutical Society of Northern Ireland, Pharmacy Forum NI, Community Pharmacy NI, the Department of Health, the National Pharmacy Association, Numark, and the Royal Pharmaceutical Society. From the outset, the discussion framed independent prescribing not as a single service or legal change, but as a fundamental shift in how community pharmacy works.
Prescribing as an enabler, not an add-on
Setting the strategic context, Chris Garland from the Department of Health described independent prescribing as a central enabler within the Department’s vision for community pharmacy.
“Independent prescribing is not simply a legal mechanism to issue a prescription,” he told the audience. “It is the enabler that allows community pharmacy to operate at its full potential as medicines experts within local communities.”
Garland outlined four interconnected programmes underpinning that ambition: service development, digital reform, workforce transformation and legislative change. Progress across all four, he stressed, is essential if prescribing is to move from policy intent into everyday practice.
While Pharmacy First provides an important foundation, the longer-term ambition extends beyond minor illness into prevention, medicines optimisation and long-term condition management — particularly within neighbourhood health models.
A workforce ready — but at risk of being under-used
From the profession’s perspective, the commitment to independent prescribing is already evident. Marie Smith, Chair of Community Pharmacy NI, highlighted the growing number of pharmacists investing significant time and personal effort to gain prescribing qualifications.
“Pharmacists are investing heavily to gain independent prescribing qualifications,” she said. “What matters now is ensuring there are commissioned services that allow those skills to be used within community pharmacy.”
Smith acknowledged that Pharmacy First offers early opportunities, particularly in medicines management and repeat prescribing. However, she was clear that broader commissioned services will be essential if that professional investment is to be realised.
Without them, she warned, there is a real risk that qualified prescribers may be drawn into general practice or hospital roles where prescribing opportunities are already embedded. Retaining that expertise within community pharmacy will be critical to the sector’s future.
Learning from experience elsewhere in the UK
Drawing on experience across the UK, Henry Gregg, Chief Executive of the National Pharmacy Association, was clear that Northern Ireland’s challenge is not a lack of capability.
“The challenge isn’t workforce readiness,” he said. “It’s whether the system gives pharmacists meaningful opportunities to use those skills.”
That concern was echoed by several panellists, who warned that failing to create the right service environment risks losing a generation of highly skilled pharmacists to other parts of the health and care system.
Offering a practitioner’s perspective, Jonathan Burton, Chair of RPS Scotland and a community pharmacist with ten years’ experience as an independent prescriber, reflected on how prescribing reshapes professional identity.
“Independent prescribing has moved pharmacy from a rules-based profession to a decision-making profession,” he said. “That brings autonomy and professional satisfaction — but it also brings responsibility.”
Burton emphasised that as pharmacists take on more complex clinical decisions, structured support becomes essential. Clinical supervision, governance frameworks and ongoing professional development were all highlighted as critical to protecting both patients and practitioners — particularly as newly qualified pharmacists enter practice with prescribing responsibilities earlier than ever before.
Regulation, confidence and leadership
From a regulatory standpoint, Canice Ward of the Pharmaceutical Society of Northern Ireland reinforced that public protection must remain central as prescribing expands.
“Clear professional standards and guidance give pharmacists the confidence to practise safely and consistently,” he said.
The panel broadly agreed that strong standards are not barriers to progress, but essential enablers that allow prescribing to develop with confidence and consistency.
Sheelin McKeagney, Chair of Pharmacy Forum NI, described independent prescribing as a “monumental change” for the profession — one that requires a parallel evolution in leadership and culture.
“Supporting pharmacists to work within their competence, and protecting those early in their careers, will be critical,” he said, particularly as roles and responsibilities shift across teams.
Capacity, supervision and the reality on the ground
Capacity emerged as a recurring theme throughout the discussion. Independent prescribing requires pharmacists to spend more time in clinical consultations and decision-making, which in turn demands a well-supported and empowered pharmacy team.
Panellists repeatedly highlighted the critical role pharmacy technicians play in releasing pharmacist capacity. While supervision changes are already enabling new ways of working elsewhere in the UK, Northern Ireland’s lack of a regulated pharmacy technician workforce was acknowledged as a significant constraint.
Both Marie Smith and Chris Garland recognised that many technicians already possess extensive expertise, but without regulation their contribution remains limited. Regulation, the panel agreed, would allow technicians to work to the full extent of their competence and support a more clinically focused pharmacy model.
Alongside this, speakers reflected on the human impact of change when it moves too quickly. Drawing on experience from Scotland and Wales, Burton noted that rapid expansion without adequate support can place significant strain on individuals and teams.
A window of opportunity for Northern Ireland
Despite these challenges, the tone of the discussion was notably optimistic. Several panellists suggested that Northern Ireland’s slower pace of implementation may, in fact, offer a strategic advantage.
It creates time, time to prepare teams, strengthen leadership capability, embed supervision and develop the right support structures before responsibilities expand further.
As Harry McQuillan of Numark observed, independent prescribing works best when community pharmacy is recognised and resourced as a care setting, with the right people doing the right work at the right level.
A confident path forward
By the close of the session, there was clear consensus: independent prescribing represents the future of community pharmacy in Northern Ireland.
The profession is ready. The ambition is clear. What remains is the careful work of sequencing — aligning workforce regulation, digital infrastructure, commissioning and leadership so that prescribing strengthens, rather than stretches, the system.
Independent prescribing is not about changing the essence of community pharmacy. It is about enabling pharmacists to deliver the level of care they are already trained to provide — safely, confidently and sustainably — at the heart of their communities.
